Hollencrest Capital Management Meridian Bioscience Inc Transaction History

Hollencrest Capital Management

  • $2.36 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023
BUY
$31.15 - $33.39 $168,210 - $180,306
5,400 New
5,400 $179,000
Q2 2018

Jul 10, 2018
SELL
$13.8 - $16.8 $488,520 - $594,720
-35,400 Closed
0 $0
Q3 2017

Oct 10, 2017
BUY
$13.45 - $14.35 $476,130 - $507,990
35,400
35,400 $506,000

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Hollencrest Capital Management Portfolio

Follow Hollencrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email